We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$327B
AUM Growth
+$39.5B
Cap. Flow
+$29.4B
Cap. Flow %
8.99%
Top 10 Hldgs %
41.94%
Holding
5,455
New
406
Increased
1,053
Reduced
2,806
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Consumer Discretionary 7.25%
3 Financials 7.18%
4 Communication Services 6.16%
5 Healthcare 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
4676
PUT
Arrowhead Research
ARWR
$11.9B
-53,000
Closed -$1.52M
ASML icon
4677
PUT
ASML
ASML
$626B
-45,900
Closed -$44.5M
ASND icon
4678
CALL
Ascendis Pharma A/S
ASND
$16B
-119,720
Closed -$18.1M
ASND icon
4679
PUT
Ascendis Pharma A/S
ASND
$16B
-72,500
Closed -$11M
ATRA icon
4680
Atara Biotherapeutics
ATRA
$75.5M
-2,706
Closed -$47K
ATS icon
4681
ATS Corp
ATS
$2.64B
-15,350
Closed -$518K
AUPH icon
4682
CALL
Aurinia Pharmaceuticals
AUPH
$1.91B
-42,500
Closed -$213K
AUPH icon
4683
PUT
Aurinia Pharmaceuticals
AUPH
$1.91B
-42,500
Closed -$213K
AVGO icon
4684
PUT
Broadcom
AVGO
$1.85T
-542,000
Closed -$71.8M
AXON
4685
CALL
Axon Enterprise
AXON
$42.5B
-88,600
Closed -$27.7M
AXON
4686
PUT
Axon Enterprise
AXON
$42.5B
-69,700
Closed -$21.8M
AXP icon
4687
PUT
American Express
AXP
$227B
-31,500
Closed -$7.17M
AXSM icon
4688
CALL
Axsome Therapeutics
AXSM
$11.2B
-27,500
Closed -$2.19M
AXSM icon
4689
PUT
Axsome Therapeutics
AXSM
$11.2B
-27,500
Closed -$2.19M
AZN icon
4690
PUT
AstraZeneca
AZN
$263B
-45,450
Closed -$6.16M
AZTA icon
4691
PUT
Azenta
AZTA
$1.3B
-77,000
Closed -$4.64M
AZO icon
4692
PUT
AutoZone
AZO
$49.2B
-500
Closed -$1.58M
BA icon
4693
PUT
Boeing
BA
$171B
-415,000
Closed -$80.1M
BABA icon
4694
PUT
Alibaba
BABA
$293B
-155,800
Closed -$11.3M
BAC icon
4695
PUT
Bank of America
BAC
$435B
-2,017,900
Closed -$76.5M
BBIO icon
4696
CALL
BridgeBio Pharma
BBIO
$15.7B
-30,000
Closed -$928K
BBIO icon
4697
PUT
BridgeBio Pharma
BBIO
$15.7B
-36,500
Closed -$1.13M
BBVA icon
4698
Banco Bilbao Vizcaya Argentaria
BBVA
$154B
-5,901
Closed -$69.9K
BBY icon
4699
PUT
Best Buy
BBY
$18.2B
-431,900
Closed -$35.4M
BCRX icon
4700
PUT
BioCryst Pharmaceuticals
BCRX
$2.28B
-20,000
Closed -$102K

Similar funds

Barclays's Q2 2024 Portfolio in Review

As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.

  • Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
  • Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
  • Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
  • Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
  • Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
  • Barclays opened 406 new positions and closed 646 in Q2 2024.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $327B.

Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.